Federal health officials have agreed to import a vaccine that never been used in the United States to help fight against the spread of meningitis at Princeton University.
The Food and Drug Administration approved bringing in the drug Bexsero for use against type B Meningitis.
Princeton has had seven cases so far this year.
Bexsero has been approved in Europe and Australia, but not the United States.
Officials from the school and the Centers for Disease Control are still deciding whether they will offer the vaccine to students. They say if they do, it will be optional.